BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND SMAD2, MADH2, 4087, ENSG00000175387, MGC34440, MGC22139, hMAD-2, MADR2, JV18-1, hSMAD2, JV18 AND Treatment
93 results:

  • 1. The role of thrombomodulin in modulating ITGB3 expression and its implications for triple-negative breast cancer progression.
    Chang YJ; Prince GMSH; Wei PL; Batzorig U; Huang CY; Hung CS; Chang TC
    Cell Biol Int; 2024 Feb; 48(2):216-228. PubMed ID: 38081783
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Glutamine deficiency drives transforming growth factor-β signaling activation that gives rise to myofibroblastic carcinoma-associated fibroblasts.
    Mezawa Y; Wang T; Daigo Y; Takano A; Miyagi Y; Yokose T; Yamashita T; Yang L; Maruyama R; Seimiya H; Orimo A
    Cancer Sci; 2023 Nov; 114(11):4376-4387. PubMed ID: 37706357
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A potential tumor marker: Chaperonin containing TCP‑1 controls the development of malignant tumors (Review).
    Zheng L; Chen X; Zhang L; Qin N; An J; Zhu J; Jin H; Tuo B
    Int J Oncol; 2023 Sep; 63(3):. PubMed ID: 37539774
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. STAT3 inhibition enhances gemcitabine sensitivity in pancreatic cancer by suppressing EMT, immune escape and inducing oxidative stress damage.
    Guo H; Hu Z; Yang X; Yuan Z; Gao Y; Chen J; Xie L; Chen C; Guo Y; Bai Y
    Int Immunopharmacol; 2023 Oct; 123():110709. PubMed ID: 37515849
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. 5-Azacytidine- and retinoic-acid-induced reprogramming of DCCs into dormancy suppresses metastasis via restored TGF-β-SMAD4 signaling.
    Singh DK; Carcamo S; Farias EF; Hasson D; Zheng W; Sun D; Huang X; Cheung J; Nobre AR; Kale N; Sosa MS; Bernstein E; Aguirre-Ghiso JA
    Cell Rep; 2023 Jun; 42(6):112560. PubMed ID: 37267946
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Effective inhibition of breast cancer stem cell properties by quercetin-loaded solid lipid nanoparticles via reduction of smad2/Smad3 phosphorylation and β-catenin signaling pathway in triple-negative breast cancer.
    Hatami M; Kouchak M; Kheirollah A; Khorsandi L; Rashidi M
    Biochem Biophys Res Commun; 2023 Jul; 664():69-76. PubMed ID: 37141640
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Nodal promotes colorectal cancer survival and metastasis through regulating SCD1-mediated ferroptosis resistance.
    Wu T; Wan J; Qu X; Xia K; Wang F; Zhang Z; Yang M; Wu X; Gao R; Yuan X; Fang L; Chen C; Yin L
    Cell Death Dis; 2023 Mar; 14(3):229. PubMed ID: 37002201
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Local Recurrence After breast-Conserving Therapy in Patients With Multiple Ipsilateral breast cancer: Results From ACOSOG Z11102 (Alliance).
    Boughey JC; Rosenkranz KM; Ballman KV; McCall L; Haffty BG; Cuttino LW; Kubicky CD; Le-Petross HT; Giuliano AE; Van Zee KJ; Hunt KK; Hahn OM; Carey LA; Partridge AH
    J Clin Oncol; 2023 Jun; 41(17):3184-3193. PubMed ID: 36977292
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Heat treatment-induced autophagy promotes breast cancer cell invasion and metastasis via TGF-
    Li Z; Lu C; Wang F; Guo H; Wang Z; Yin H; Li J
    PeerJ; 2023; 11():e14640. PubMed ID: 36650834
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Recombinant human chorionic gonadotropin induces signaling pathways towards cancer prevention in the breast of BRCA1/2 mutation carriers.
    Su Y; Dang NM; Depypere H; Santucci-Pereira J; Gutiérrez-Díez PJ; Kanefsky J; Janssens JP; Russo J
    Eur J Cancer Prev; 2023 Mar; 32(2):126-138. PubMed ID: 35881946
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Stem gene expression in breast tumors during chemotherapy: Connection with the main clinical and morphological factors and the disease outcome.
    Ibragimova MK; Tsyganov MM; Deryusheva IV; Slonimskaya EM; Litviakov NV
    J Cancer Res Ther; 2022; 18(1):89-95. PubMed ID: 35381768
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. TGF-β1 inhibits human trophoblast cell invasion by upregulating kisspeptin expression through ERK1/2 but not SMAD signaling pathway.
    Fang L; Yan Y; Gao Y; Wu Z; Wang Z; Yang S; Cheng JC; Sun YP
    Reprod Biol Endocrinol; 2022 Jan; 20(1):22. PubMed ID: 35101033
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Epigenetic regulation of triple negative breast cancer (TNBC) by TGF-β signaling.
    Vishnubalaji R; Alajez NM
    Sci Rep; 2021 Jul; 11(1):15410. PubMed ID: 34326372
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Dexamethasone enhances the lung metastasis of breast cancer via a PI3K-SGK1-CTGF pathway.
    Zhang Y; Shi G; Zhang H; Xiong Q; Cheng F; Wang H; Luo J; Zhang Y; Shi P; Xu J; Fu J; Chen N; Cheng L; Li Y; Dai L; Yang Y; Yu D; Zhang S; Deng H
    Oncogene; 2021 Sep; 40(35):5367-5378. PubMed ID: 34272474
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Resveratrol Enhances Inhibition Effects of Cisplatin on Cell Migration and Invasion and Tumor Growth in breast cancer MDA-MB-231 Cell Models In Vivo and In Vitro.
    Yang MD; Sun Y; Zhou WJ; Xie XZ; Zhou QM; Lu YY; Su SB
    Molecules; 2021 Apr; 26(8):. PubMed ID: 33921192
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. MMP11 promotes the proliferation and progression of breast cancer through stabilizing smad2 protein.
    Zhuang Y; Li X; Zhan P; Pi G; Wen G
    Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649832
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Key Epigenetic Events Involved in the Maintenance of breast cancer Stem Cells.
    Pourmahdi M; Saber A; Rajabi A; Abdolahi S; Ebrahimi P; Safaralizadeh R
    Curr Stem Cell Res Ther; 2021; 16(7):877-887. PubMed ID: 33563177
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. SIPA1 enhances smad2/3 expression to maintain stem cell features in breast cancer cells.
    Wang N; Weng J; Xia J; Zhu Y; Chen Q; Hu D; Zhang X; Sun R; Feng J; Minato N; Gong Y; Su L
    Stem Cell Res; 2020 Dec; 49():102099. PubMed ID: 33296812
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. OSR1 phosphorylates the smad2/3 linker region and induces TGF-β1 autocrine to promote EMT and metastasis in breast cancer.
    Li Y; Li L; Qin J; Wu J; Dai X; Xu J
    Oncogene; 2021 Jan; 40(1):68-84. PubMed ID: 33051597
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Positron Emission Tomography Imaging of Functional Transforming Growth Factor β (TGFβ) Activity and Benefit of TGFβ Inhibition in Irradiated Intracranial Tumors.
    Gonzalez-Junca A; Reiners O; Borrero-Garcia LD; Beckford-Vera D; Lazar AA; Chou W; Braunstein S; VanBrocklin H; Franc BL; Barcellos-Hoff MH
    Int J Radiat Oncol Biol Phys; 2021 Feb; 109(2):527-539. PubMed ID: 33007434
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 5.